1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. VINCERX PHARMA INC
Vincerx Pharma Inc XNAS: VINC

Watchlist

Portfolio

Alert

Share


Insider Trading disclosures for Vincerx Pharma Inc

The latest disclosure was made by Ahmed M. Hamdy in Vincerx Pharma Inc where a trade of 53,254 Stock Option (right to buy) done was reported to US exchanges on Aug. 12, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Ahmed M. Hamdy Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Aug 2024 53,254 0 - - Stock Option (right to buy)
Ahmed M. Hamdy Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 146,746 146,746 - - Stock Option (right to buy)
Ahmed M. Hamdy Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Aug 2024 146,746 0 - - Stock Option (right to buy)
Ahmed M. Hamdy Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 90,000 90,000 - - Stock Option (right to buy)
Ahmed M. Hamdy Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Aug 2024 90,000 0 - - Stock Option (right to buy)
Ahmed M. Hamdy Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 60,000 60,000 - - Stock Option (right to buy)
Ahmed M. Hamdy Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 127,500 127,500 - - Stock Option (right to buy)
Ahmed M. Hamdy Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Aug 2024 60,000 0 - - Stock Option (right to buy)
Ahmed M. Hamdy Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 60,000 60,000 - - Stock Option (right to buy)
Ahmed M. Hamdy Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Aug 2024 60,000 0 - - Stock Option (right to buy)
Ahmed M. Hamdy Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Aug 2024 127,500 0 - - Stock Option (right to buy)
Ahmed M. Hamdy Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 53,254 200,000 - - Stock Option (right to buy)
Raquel E. Izumi Director, See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Aug 2024 60,000 0 - - Stock Option (right to buy)
Raquel E. Izumi Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 41,250 165,000 - - Stock Option (right to buy)
Raquel E. Izumi Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 60,000 60,000 - - Stock Option (right to buy)
Raquel E. Izumi Director, See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Aug 2024 60,000 0 - - Stock Option (right to buy)
Raquel E. Izumi Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 60,000 60,000 - - Stock Option (right to buy)
Raquel E. Izumi Director, See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Aug 2024 90,000 0 - - Stock Option (right to buy)
Raquel E. Izumi Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 90,000 90,000 - - Stock Option (right to buy)
Raquel E. Izumi Director, See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Aug 2024 123,750 0 - - Stock Option (right to buy)
Raquel E. Izumi Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 123,750 123,750 - - Stock Option (right to buy)
Raquel E. Izumi Director, See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Aug 2024 41,250 0 - - Stock Option (right to buy)
Raquel E. Izumi Director, See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Aug 2024 76,500 0 - - Stock Option (right to buy)
Raquel E. Izumi Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 76,500 76,500 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 56,000 56,000 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Aug 2024 200,000 0 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 200,000 200,000 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Aug 2024 55,250 0 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 55,250 55,250 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Aug 2024 58,000 0 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 58,000 58,000 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Aug 2024 56,000 0 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Aug 2024 86,000 0 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 86,000 86,000 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Aug 2024 93,750 0 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 93,750 93,750 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 12 Aug 2024 31,250 0 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 31,250 125,000 - - Stock Option (right to buy)
Brian J. Druker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2024 15,000 15,000 - - Stock Option (right to buy)
Laura I. Bushnell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2024 15,000 15,000 - - Stock Option (right to buy)
John H. Lee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2024 15,000 15,000 - - Stock Option (right to buy)
Francisco D. Salva Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2024 15,000 15,000 - - Stock Option (right to buy)
Ruth E. Stevens Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2024 15,000 15,000 - - Stock Option (right to buy)
Ahmed M. Hamdy Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2024 53,254 200,000 - - Stock Option (right to buy)
Raquel E. Izumi Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2024 41,250 165,000 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2024 31,250 125,000 - - Stock Option (right to buy)
Ahmed M. Hamdy Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 146,746 146,746 - - Stock Option (right to buy)
Raquel E. Izumi Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 123,750 123,750 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2024 93,750 93,750 - - Stock Option (right to buy)
Alexander A. Seelenberger See Remarks Purchase of securities on an exchange or from another person at price $ 0.95 per share. 11 Aug 2023 10,500 30,280 - 0.9 9,968 Common Stock
Ahmed M. Hamdy Director, See Remarks Purchase of securities on an exchange or from another person at price $ 0.95 per share. 09 Aug 2023 16,900 90,660 - 0.9 15,994 Common Stock
Ahmed M. Hamdy Director, See Remarks Purchase of securities on an exchange or from another person at price $ 0.96 per share. 09 Aug 2023 5,400 96,060 - 1.0 5,167 Common Stock
Raquel E. Izumi Director, See Remarks Purchase of securities on an exchange or from another person at price $ 0.90 per share. 09 Aug 2023 13,036 81,774 - 0.9 11,735 Common Stock
Raquel E. Izumi Director, See Remarks Purchase of securities on an exchange or from another person at price $ 0.93 per share. 09 Aug 2023 3,440 85,214 - 0.9 3,199 Common Stock
Brian J. Druker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 15,000 15,000 - - Stock Option (right to buy)
Laura I. Bushnell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 15,000 15,000 - - Stock Option (right to buy)
John H. Lee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 15,000 15,000 - - Stock Option (right to buy)
Francisco D. Salva Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 15,000 15,000 - - Stock Option (right to buy)
Ruth E. Stevens Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 15,000 15,000 - - Stock Option (right to buy)
Ahmed M. Hamdy Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2023 90,000 90,000 - - Stock Option (right to buy)
Raquel E. Izumi Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2023 90,000 90,000 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2023 86,000 86,000 - - Stock Option (right to buy)
Ahmed M. Hamdy Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.87 per share. 14 Dec 2022 35,280 73,760 - 0.9 30,538 Common Stock
Raquel E. Izumi Director, See Remarks Purchase of securities on an exchange or from another person at price $ 0.88 per share. 14 Dec 2022 28,738 68,738 - 0.9 25,427 Common Stock
Ahmed M. Hamdy Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2022 60,000 60,000 - - Stock Option (right to buy)
Raquel E. Izumi Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2022 60,000 60,000 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2022 56,000 56,000 - - Stock Option (right to buy)
Ahmed M. Hamdy Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Aug 2022 60,000 60,000 - - Stock Option (right to buy)
Raquel E. Izumi Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Aug 2022 60,000 60,000 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Aug 2022 58,000 58,000 - - Stock Option (right to buy)
Christopher P. Lowe Director Purchase of securities on an exchange or from another person at price $ 1.65 per share. 24 Aug 2022 11,600 40,000 - 1.6 19,139 Common Stock
Christopher P. Lowe Director Purchase of securities on an exchange or from another person at price $ 1.65 per share. 24 Aug 2022 18,400 28,400 - 1.6 30,299 Common Stock
Raquel E. Izumi Director, See Remarks Purchase of securities on an exchange or from another person at price $ 1.41 per share. 27 Jun 2022 40,000 40,000 - 1.4 56,312 Common Stock
Ahmed M. Hamdy Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.41 per share. 23 Jun 2022 24,200 38,480 - 1.4 34,137 Common Stock
Laura I. Bushnell Director Purchase of securities on an exchange or from another person at price $ 1.91 per share. 09 Jun 2022 15,000 19,202 - 1.9 28,625 Common Stock
Christopher P. Lowe Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 15,000 15,000 - - Stock Option (right to buy)
Brian J. Druker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 15,000 15,000 - - Stock Option (right to buy)
Andrew McDonald Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 15,000 15,000 - - Stock Option (right to buy)
Laura I. Bushnell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 15,000 15,000 - - Stock Option (right to buy)
John H. Lee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 15,000 15,000 - - Stock Option (right to buy)
Francisco D. Salva Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 15,000 15,000 - - Stock Option (right to buy)
Ruth E. Stevens Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2022 15,000 15,000 - - Stock Option (right to buy)
Ahmed M. Hamdy Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2022 127,500 127,500 - - Stock Option (right to buy)
Xiaoming Zhang Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2022 34,000 34,000 - - Stock Option (right to buy)
Raquel E. Izumi Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2022 76,500 76,500 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2022 55,250 55,250 - - Stock Option (right to buy)
Hermes de Jesus Garban Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2022 55,250 55,250 - - Stock Option (right to buy)
Sooin Hwang Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2022 34,000 34,000 - - Stock Option (right to buy)
Sooin Hwang Chief Business Officer Purchase of securities on an exchange or from another person at price $ 10.00 per share. 23 Dec 2021 3,000 390,491 - 10 30,000 Common Stock
Ahmed M. Hamdy Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 10.02 per share. 22 Dec 2021 6,450 14,280 - 10.0 64,650 Common Stock
Laura I. Bushnell Director Purchase of securities on an exchange or from another person at price $ 10.48 per share. 22 Dec 2021 2,402 4,202 - 10.5 25,173 Common Stock
Alexander A. Seelenberger Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 10.34 per share. 22 Dec 2021 2,417 12,493 - 10.3 24,988 Common Stock
Raquel E. Izumi Director, See Remarks Purchase of securities on an exchange or from another person at price $ 11.96 per share. 04 Aug 2021 1,000 1,000 - 12.0 11,960 Common Stock
Laura I. Bushnell Director Purchase of securities on an exchange or from another person at price $ 12.94 per share. 30 Jun 2021 1,800 1,800 - 12.9 23,297 Common Stock
Sooin Hwang Chief Business Officer Purchase of securities on an exchange or from another person at price $ 12.66 per share. 30 Jun 2021 500 385,575 - 12.7 6,330 Common Stock
Christopher P. Lowe Director Purchase of securities on an exchange or from another person at price $ 12.59 per share. 29 Jun 2021 6,400 6,400 - 12.6 80,576 Common Stock
Christopher P. Lowe Director Purchase of securities on an exchange or from another person at price $ 12.66 per share. 29 Jun 2021 3,600 10,000 - 12.7 45,576 Common Stock
Ahmed M. Hamdy Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 12.77 per share. 29 Jun 2021 7,830 7,830 - 12.8 99,989 Common Stock
Andrew McDonald Director Purchase of securities on an exchange or from another person at price $ 12.38 per share. 29 Jun 2021 20,000 20,000 - 12.4 247,600 Common Stock
John H. Lee Director Purchase of securities on an exchange or from another person at price $ 12.71 per share. 29 Jun 2021 799 799 - 12.7 10,159 Common Stock
Alexander A. Seelenberger Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 12.61 per share. 29 Jun 2021 7,950 7,950 - 12.6 100,260 Common Stock
Christopher P. Lowe Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2021 20,000 20,000 - - Stock Option (right to buy)
Brian J. Druker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2021 20,000 20,000 - - Stock Option (right to buy)
Andrew McDonald Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2021 20,000 20,000 - - Stock Option (right to buy)
Laura I. Bushnell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2021 20,000 20,000 - - Stock Option (right to buy)
John H. Lee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2021 20,000 20,000 - - Stock Option (right to buy)
Francisco D. Salva Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2021 20,000 20,000 - - Stock Option (right to buy)
Ruth E. Stevens Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 May 2021 20,000 20,000 - - Stock Option (right to buy)
Hermes de Jesus Garban Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2021 150,000 150,000 - - Stock Option (right to buy)
Andrew McDonald Director Other type of transaction at price $ 0.00 per share. 28 Jan 2021 808,471 808,471 - 0 Common Stock
Andrew McDonald Director Other type of transaction at price $ 0.00 per share. 28 Jan 2021 1,616,942 0 - 0 Common Stock
Mark A. Mccamish Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2020 6,667 6,667 - - Stock Option (right to buy)
Christopher P. Lowe Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2020 6,667 6,667 - - Stock Option (right to buy)
Ahmed Hamdy Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2020 1,618,199 1,618,199 - - Common Stock
Brian J. Druker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2020 6,667 6,667 - - Stock Option (right to buy)
Brian J. Druker Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2020 54,806 54,806 - - Common Stock
Andrew McDonald Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2020 6,667 6,667 - - Stock Option (right to buy)
Raquel E. Izumi Director, Chief Operations Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2020 1,618,199 1,618,199 - - Common Stock
Laura I. Bushnell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2020 6,667 6,667 - - Stock Option (right to buy)
John H. Lee Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2020 6,667 6,667 - - Stock Option (right to buy)
Francisco D. Salva Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2020 6,667 6,667 - - Stock Option (right to buy)
Alexander A. Seelenberger Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2020 200,000 200,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters